Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05324098 · ClinicalTrials.gov registry record · NA
Leveraging Technology to Achieve Equity for Men With Prostate Cancer on Androgen Deprivation Therapy
A NA study of Prostate Cancer, sponsored by University of California, San Francisco.
- Completed
- Registry status
- NA
- Development phase
- 47
- Enrollment target
- 2
- Study locations
NCT05324098: Completed NA study of Prostate Cancer, sponsored by University of California, San Francisco.
NCT05324098 is a NA study of Prostate Cancer that has completed, run by University of California, San Francisco. The registered enrollment target is 47 participants, below the 608-participant average among 735 other Prostate Cancer trials with a reported enrollment target (92% lower). The trial reports 2 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05324098, a NA study of Prostate Cancer, has completed, sponsored by University of California, San Francisco.
- COMPLETED
- Registry status
- NA
- Development phase
- 47 participants
- Enrollment target
- 2
- Study locations
Study Summary
This clinical trial studies a digital platform, the supportive therapy in androgen deprivation (STAND-T), in achieving equity for men undergoing treatment with androgen deprivation therapy for prostate cancer. STAND-T is a digital platform that provides prostate health information, evidence-based materials and resources. STAND-T may help improve health, address symptoms, and promote equity in men with prostate cancer.
Primary Outcome
The point estimation and 95% confidence interval (CI) of the percentage of participants who complete the 3-month study will be obtained overall and by race/ethnicity and geography.
Conditions Studied
Interventions
- OTHER Survey Administration
- OTHER STAND-T platform
- OTHER Text Messages
Study Locations (2)
California
- Zuckerberg San Francisco General Hospital - San Francisco
- University of California, San Francisco - San Francisco
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 47 participants |
| Start Date | 2022-03-08 |
| Est. Completion | 2023-07-31 |
| Phase | NA |
What the finished NCT05324098 record still lists
NCT05324098 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 47 participants, a relatively small participant target, below the 608-participant average among 735 other Prostate Cancer trials with a reported enrollment target (92% lower).
The record links to 1 condition, with Prostate Cancer appearing as the primary indexed condition, and to 3 interventions - of which Survey Administration is the first listed.
NCT05324098 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT05324098 about?
NCT05324098 is a clinical study titled "Leveraging Technology to Achieve Equity for Men With Prostate Cancer on Androgen Deprivation Therapy". This clinical trial studies a digital platform, the supportive therapy in androgen deprivation (STAND-T), in achieving equity for men undergoing treatment with androgen deprivation therapy for prostate cancer. STAND-T is a digital platform that provides prostate health information, evidence-based ma...
What is the current status of trial NCT05324098?
This trial is currently completed. It is a NA study. The enrollment target is 47 participants. The study started on 2022-03-08. Estimated completion is 2023-07-31.
What conditions does trial NCT05324098 study?
This clinical trial studies the following conditions: Prostate Cancer.
What interventions are being tested in trial NCT05324098?
The interventions under investigation include: Survey Administration (OTHER), STAND-T platform (OTHER), Text Messages (OTHER).
Who is sponsoring clinical trial NCT05324098?
This trial is sponsored by University of California, San Francisco, which has 1,713 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05324098 being conducted?
This trial has 2 study locations across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Prostate Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05324098's enrollment target sits among peer trials
47 502nd of 735 higher than 233 of 735 other Prostate Cancer trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Prostate Cancer trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Improving Health Literacy in African-American Prostate Cancer Patients
RECRUITING · NA
-
Pilot Study to Investigate Magnetic Resonance (MR) Image Guided Focal Therapy in Prostate Cancer
RECRUITING · NA
-
Diffusion Basis Spectrum Imaging of the Prostate
RECRUITING · NA
-
Micro-UltraSound In Cancer - Active Surveillance
RECRUITING · NA
-
Precise Oncology Interventions in Nutrition and Training (OnPoint)
RECRUITING · NA
-
SBRT Boost for Unfavorable Prostate Cancer'
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03313011 · 47 participants
The Neurobiology of Two Distinct Types of Progressive Apraxia of Speech
- NCT03467516 · 47 participants · Phase 2
Adoptive Transfer of Tumor Infiltrating Lymphocytes for Metastatic Uveal Melanoma
- NCT03886662 · 47 participants · Phase 1
A Study of LB-100 in Patients With Low or Intermediate-1 Risk Myelodysplastic Syndromes (MDS)
- NCT04013802 · 47 participants · Phase 1
TETRAVI Multivirus CTL for Treatment of EBV, CMV, Adenovirus, and BK Infections Post Allogeneic SCT.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI